Baron23
Well-Known Member
And as a bonus on the topic of abject stupidity
Sponsored by |
---|
creating 68 new jobs in the province as a result
Yeah, great fucking idea....next, we'll put a shock collar on you and if you don't behave we will have you neutered and an RFID tag inserted under your pelt...er, skin.If the technology functions as intended, it sounds like a great idea!
Ontario investing $2.5M in wearable tracing tech that will beep or vibrate if people aren’t six feet apart
The Ontario government is investing $2.5 million in wearable contact tracing technology that will alert users if they may have been exposed to the COVID-19 in the workplace and will beep or vibrate if they are within six feet of another person.toronto.ctvnews.ca
Any measure... no matter how silly most think it is.... is a good measure.Beeping's a bit much, IMO.
Yeah, but it annoys others. It's all about being considerate, for which Canadians are famous.If the beeping device appeals to them
Sorry, mate....but that's nothing but baloney to me also.Any measure... no matter how silly most think it is.... is a good measure.
No need to apologize.Sorry, mate
If they can make this technology, they can make it with an EarPod, or a simple vibration.Yeah, but it annoys others.
I stated my opinion.This is my opinion.
Fear?Why are the teachers fighting going back to work?
My girlfriend is a high school teacher.... teachers in many areas have balked at that plan, saying they don't feel safe being in a classroom until they are given the opportunity to get vaccinated against ...
Was it the Pfizer vaccine? Looks like good news.she's had the 1st shot
In December, 2020, the Israeli Government approved the BNT162b2 COVID-19 vaccine and initiated a national immunisation campaign prioritising health-care workers (HCWs), as in other countries.This campaign coincided with a third wave of COVID-19, peaking at 10 116 daily new cases by mid-January, 2021. The Sheba Medical Centre, Israel's largest hospital with 9647 HCWs, began staff vaccination on Dec 19, 2020. All HCWs, excluding those with previous SARS-CoV-2 infection, were eligible for vaccination. Clinical trial data of BNT162b2 vaccine estimated an early vaccine efficacy in preventing COVID-19 of 52·4% before dose two, and 90.5% on days 2–7 after dose two. A recent analysis of BNT162b2 vaccine data estimated vaccine efficacy of 89–91% during days 15–28 after the first dose. We examined early reductions in SARS-CoV-2 infection and COVID-19 rates in vaccinated HCWs.
It was.Was it the Pfizer vaccine?
I like @Vitolo walking stick low tech approach better.Beeping's a bit much, IMO.
My wife was glad to get back in the classroom...once safe as it was a lot less time-consuming than teaching from home. It was even worse when the schools first started back up as student attendance was optional so she had to do online and classroom teaching. Quite frankly people that think teachers have it easy or are lazy just have no real idea how much goes on behind the scenes to educate the sawn-off little savages.Why are the teachers fighting going back to work?
Same with my GF. No renumeration for this extra work... I believe it's a labor of love for most educators.student attendance was optional so she had to do online and classroom teaching
I like @Vitolo walking stick low tech approach better.
What if a more contagious variant spreads?
A more contagious variant of the virus, like the one first identified in Britain that is now spreading throughout the United States, could further complicate the path to herd immunity.
If the virus becomes more contagious, the threshold for herd immunity will go up. It may be hard for vaccines to keep pace, and precautions will be even more necessary to stem the spread.
The spread of new virus variants makes it impossible to put a firm date on when we’ll reach herd immunity or when the pandemic will end. There’s a chance a mutation could lead to a version of the virus that doesn’t respond to existing immunity, leading us to start the journey to herd immunity all over again.
Dr. [Bruce Y.] Lee said that coronaviruses have relatively high mutation rates and that it is likely that new variants of the virus will continue to emerge. “The question will be how different might these variants be,” he said. If a variant of the virus stops responding to the vaccine, “it will then be a matter of determining whether and when new vaccines will need to be produced.”
"brandnewtube.com" is not worth the effort, IMO. And that's applying critical thinking, not shirking it.
Sponsored by |
---|